Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Plasma Eosinophil Count and Patient-Centered Events in Chronic Obstructive Pulmonary Disease in Real-Life Clinical Practice.

Golpe R, Dacal D, Sanjuán-López P, Martín-Robles I, Pérez-de-Llano LA.

Arch Bronconeumol. 2019 Nov 10. pii: S0300-2896(19)30367-9. doi: 10.1016/j.arbres.2019.09.015. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31722828
2.

Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab.

Pérez de Llano LA, Dacal Rivas D, Cosío BG.

Allergy. 2019 Sep 4. doi: 10.1111/all.14035. [Epub ahead of print] No abstract available.

PMID:
31483864
3.

Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.

Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, Entrenas Costa LM, Quirce S, Barranco P, Marina Malanda N, Andrés LP, Alvarez-Gutiérrez FJ.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2277-2283.e2. doi: 10.1016/j.jaip.2019.01.017. Epub 2019 Jan 21.

4.

Should Lung Function Be Included in the Risk Stratification of Chronic Obstructive Pulmonary Disease Proposed by GesEPOC?

Golpe R, Suárez-Valor M, Veiga-Teijeiro I, Veres-Racamonde A, Pérez-de-Llano LA.

Arch Bronconeumol. 2019 Aug;55(8):436-437. doi: 10.1016/j.arbres.2018.12.007. Epub 2019 Jan 11. English, Spanish. No abstract available.

5.

[Palliative care for patients with chronic respiratory failure].

Pérez de Llano LA.

Gac Sanit. 2018 Jul - Aug;32(4):383-385. doi: 10.1016/j.gaceta.2018.04.006. Epub 2018 May 23. Spanish.

6.

Mortality in COPD patients according to clinical phenotypes.

Golpe R, Suárez-Valor M, Martín-Robles I, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez de Llano LA.

Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1433-1439. doi: 10.2147/COPD.S159834. eCollection 2018.

7.

Risk Stratification in Chronic Obstructive Pulmonary Disease. Can the Spanish Guidelines be Improved?

Golpe R, Suárez-Valor M, Castro-Añón O, Pérez-de-Llano LA.

Arch Bronconeumol. 2018 Oct;54(10):533-535. doi: 10.1016/j.arbres.2018.01.035. Epub 2018 Mar 2. English, Spanish. No abstract available.

8.

Prognosis of Obesity Hypoventilation Syndrome With and Without Concomitant Obstructive Sleep Apnea Syndrome.

Rodriguez Alvarez A, Méndez Marote L, Castro Añón O, Golpe Gómez R, Pérez de Llano LA.

Arch Bronconeumol. 2018 Apr;54(4):230-231. doi: 10.1016/j.arbres.2017.08.012. Epub 2017 Nov 3. English, Spanish. No abstract available.

9.

The Need for Palliative Care in Chronic Respiratory Patients With Non-Malignant Disease.

Nieto Cano S, Golpe Gómez R, Pérez de Llano LA.

Arch Bronconeumol. 2018 Jan;54(1):57. doi: 10.1016/j.arbres.2017.07.018. Epub 2017 Sep 14. English, Spanish. No abstract available.

10.

Farmer's lung disease: Analysis of 75 cases.

Cano-Jiménez E, Rubal D, Pérez de Llano LA, Mengual N, Castro-Añón O, Méndez L, Golpe R, Sanjuán P, Martín I, Veres A.

Med Clin (Barc). 2017 Nov 22;149(10):429-435. doi: 10.1016/j.medcli.2017.03.052. Epub 2017 Jun 3. English, Spanish.

PMID:
28587854
11.

Safety of suspending asthma treatment before performing a methacholine challenge test.

Carballido Vázquez AM, Muñiz C, Pérez de Llano LA.

Arch Bronconeumol. 2017 Oct;53(10):601. doi: 10.1016/j.arbres.2017.03.023. Epub 2017 Apr 28. English, Spanish. No abstract available.

12.

Quality Indicators of Asthma Care Derived From the Spanish Guidelines for Asthma Management (GEMA 4.0): A Multidisciplinary Team Report.

Quirce S, Delgado J, Entrenas LM, Grande M, Llorente C, López Viña A, Martínez Moragón E, Mascarós E, Molina J, Olaguibel JM, Pérez de Llano LA, Perpiñá Tordera M, Quintano JA, Rodríguez M, Román-Rodriguez M, Sastre J, Trigueros JA, Valero AL, Zoni AC, Plaza V; ASMAFORUM II Group.

J Investig Allergol Clin Immunol. 2017;27(1):69-73. doi: 10.18176/jiaci.0121. No abstract available.

13.

Clinical significance of the oral corticosteroid reversibility test in asthma with fixed airflow obstruction.

Riaño Pérez A, Pérez de Llano LA, Mengual N, Golpe R.

Arch Bronconeumol. 2017 Jan;53(1):40. doi: 10.1016/j.arbres.2016.07.002. Epub 2016 Jul 30. English, Spanish. No abstract available.

14.

Blood Pressure Profile and Hypertensive Organ Damage in COPD Patients and Matched Controls. The RETAPOC Study.

Golpe R, Mateos-Colino A, Testa-Fernández A, Pena-Seijo M, Rodríguez-Enríquez M, González-Juanatey C, Martín-Vázquez FJ, Pose-Reino A, Domínguez-Pin N, Garnacho-Gayarre N, Pérez-de-Llano LA.

PLoS One. 2016 Jun 30;11(6):e0157932. doi: 10.1371/journal.pone.0157932. eCollection 2016.

15.

Asthma, Chronic Obstructive Pulmonay Disease and Other Combinations.

Pérez de Llano LA, Cosío BG.

Arch Bronconeumol. 2016 Oct;52(10):499-500. doi: 10.1016/j.arbres.2016.03.003. Epub 2016 Apr 25. English, Spanish. No abstract available.

16.

Cost-effectiveness of Continuous Positive Airway Pressure Treatment in Moderate-Severe Obstructive Sleep Apnea Syndrome.

Català R, Villoro R, Merino M, Sangenís S, Colomés L, Hernández Flix S, Pérez de Llano LA.

Arch Bronconeumol. 2016 Sep;52(9):461-9. doi: 10.1016/j.arbres.2016.02.005. Epub 2016 Mar 15. English, Spanish.

17.

Cost Effectiveness of Outpatient Asthma Clinics.

Pérez de Llano LA, Villoro R, Merino M, Gómez Neira Mdel C, Muñiz C, Hidalgo Á.

Arch Bronconeumol. 2016 Apr;52(4):196-203. doi: 10.1016/j.arbres.2015.09.009. Epub 2015 Nov 6. English, Spanish.

18.

Prognostic value of multidimensional indices in ambulatory COPD patients.

Golpe R, Mengual-Macenlle N, Martín-Robles I, Sanjuán-López P, Pérez de Llano LA.

Eur J Intern Med. 2015 Oct;26(8):e38-9. doi: 10.1016/j.ejim.2015.05.008. Epub 2015 May 23. No abstract available.

PMID:
26004743
19.

Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure.

Golpe R, Mengual-Macenlle N, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez-de-Llano LA.

Lung. 2015 Aug;193(4):497-503. doi: 10.1007/s00408-015-9731-9. Epub 2015 Apr 30.

PMID:
25926292
20.

Cortico-dependent Asthma: Our Clinical Experience.

Pérez de Llano LA, García Rivero JL, Pallares A, Mengual N, Golpe R.

Arch Bronconeumol. 2015 Dec;51(12):660-1. doi: 10.1016/j.arbres.2015.02.017. Epub 2015 Apr 21. English, Spanish. No abstract available.

21.

Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome.

Castro-Añón O, Pérez de Llano LA, De la Fuente Sánchez S, Golpe R, Méndez Marote L, Castro-Castro J, González Quintela A.

PLoS One. 2015 Feb 11;10(2):e0117808. doi: 10.1371/journal.pone.0117808. eCollection 2015.

22.

Cost-Effectiveness of Asthma Management in a Hospital-Based Adult Asthma Clinic in Spain.

Perez de Llano LA, Villoro R, Hidalgo A, Merino M.

Value Health. 2014 Nov;17(7):A596-7. doi: 10.1016/j.jval.2014.08.2059. Epub 2014 Oct 26. No abstract available.

23.

Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.

Golpe R, Sanjuán López P, Cano Jiménez E, Castro Añón O, Pérez de Llano LA.

Arch Bronconeumol. 2014 Aug;50(8):318-24. doi: 10.1016/j.arbres.2013.12.013. Epub 2014 Feb 25. English, Spanish.

24.

Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension.

Golpe R, Castro-Añón O, Pérez-de-Llano LA, González-Juanatey C, Muñiz-Fernández C, Testa-Fernández A, Pérez-Fernández R.

Heart Lung. 2014 Jan-Feb;43(1):72-6. doi: 10.1016/j.hrtlng.2013.08.007. Epub 2013 Sep 14.

PMID:
24041565
25.

Prognostic value of the Charlson comorbidity index in pulmonary embolism.

Golpe R, Pérez-de-Llano LA, Castro-Añón O.

Respiration. 2013;85(5):438. doi: 10.1159/000346982. Epub 2013 Mar 7. No abstract available.

26.

Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.

Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A.

Respir Care. 2013 Aug;58(8):1329-34. doi: 10.4187/respcare.02290. Epub 2013 Jan 15.

27.

Reply: To PMID 22897169.

Castro-Añón O, Golpe R, Pérez-de-Llano LA.

Respirology. 2013 Feb;18(2):386. doi: 10.1111/resp.12026. No abstract available.

PMID:
23231591
28.

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: a meta-analysis of 5 randomized trials in non-cancer and cancer patients.

Laporte S, Bertoletti L, Romera A, Mismetti P, Pérez de Llano LA, Meyer G.

Thromb Res. 2012 Dec;130(6):853-8. doi: 10.1016/j.thromres.2012.08.290. Epub 2012 Aug 28.

PMID:
22939430
29.

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome.

Castro-Añón O, Golpe R, Pérez-de-Llano LA, López González MJ, Escalona Velasquez EJ, Pérez Fernández R, Testa Fernández A, González Quintela A.

Respirology. 2012 Nov;17(8):1269-74. doi: 10.1111/j.1440-1843.2012.02252.x.

PMID:
22897169
30.

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism.

Golpe R, Testa-Fernández A, Pérez-de-Llano LA, Castro-Añón O, González-Juanatey C, Pérez-Fernández R, Fariñas MC.

Eur J Echocardiogr. 2011 Oct;12(10):756-61. doi: 10.1093/ejechocard/jer125. Epub 2011 Aug 15.

PMID:
21846648
31.

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients.

Golpe R, Castro-Añón O, Pérez-de-Llano LA, González-Juanatey C, Vázquez-Caruncho M, Méndez-Marote L, Fariñas MC.

J Hosp Med. 2011 May;6(5):285-9. doi: 10.1002/jhm.868.

PMID:
21661101
32.

Nitric oxide (NO) in managing asthma.

Pérez de Llano LA.

Arch Bronconeumol. 2012 Feb;48(2):35-6. doi: 10.1016/j.arbres.2011.01.006. Epub 2011 Mar 22. English, Spanish. No abstract available.

33.

Effects of omalizumab in Aspergillus-associated airway disease.

Pérez-de-Llano LA, Vennera MC, Parra A, Guallar J, Marin M, Asensio O, Ausin P, Borderías L, Fernández C, Granel C, Pérez-Pimiento A, Rubio M.

Thorax. 2011 Jun;66(6):539-40. doi: 10.1136/thx.2010.153312. Epub 2011 Mar 11. No abstract available.

PMID:
21398373
34.

[Troponin-I in hemodynamically-stable pulmonary embolism: correlation with echocardiography and computed tomography angiography].

Golpe R, Pérez-de-Llano LA, Castro-Añón O, Vázquez-Caruncho M, González-Juanatey C, Fariñas MC.

Rev Clin Esp. 2011 Feb;211(2):69-75. doi: 10.1016/j.rce.2010.06.014. Epub 2011 Feb 12. Spanish.

PMID:
21316656
35.

Necrotising pneumonia due to Finegoldia magna.

Sedano Gómez GE, Pérez de Llano LA, Pita Carretero J.

Arch Bronconeumol. 2011 Jan;47(1):54-5. doi: 10.1016/j.arbres.2010.09.007. Epub 2010 Dec 28. English, Spanish. No abstract available.

36.

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism.

Golpe R, Pérez-de-Llano LA, Fariñas MC.

Thromb Res. 2011 Apr;127(4):386. doi: 10.1016/j.thromres.2010.11.016. Epub 2010 Dec 13. No abstract available.

PMID:
21146200
37.

Shrinking lung syndrome caused by lupus myopathy.

Pérez-de-Llano LA, Castro-Añón O, López MJ, Escalona E, Teijeira S, Sánchez-Andrade A.

QJM. 2011 Mar;104(3):259-62. doi: 10.1093/qjmed/hcq095. Epub 2010 Oct 8. No abstract available.

PMID:
20934977
38.

Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study.

Pérez-de-Llano LA, Leiro-Fernández V, Golpe R, Núñez-Delgado JM, Palacios-Bartolomé A, Méndez-Marote L, Colomé-Nafria E.

Blood Coagul Fibrinolysis. 2010 Dec;21(8):744-9. doi: 10.1097/MBC.0b013e3283401406. Erratum in: Blood Coagul Fibrinolysis. 2011 Jan;22(1):79.

PMID:
20885298
39.

[Relationship between comorbidity and asthma control].

Pérez De Llano LA, González FC, Añón OC, Perea MP, Caruncho MV, Villar AB; Proyecto Camaron (Control del Asma Mediante el Análisis Regular del Óxido Nítrico).

Arch Bronconeumol. 2010 Oct;46(10):508-13. doi: 10.1016/j.arbres.2010.05.008. Epub 2010 Jul 17. Spanish.

40.

Right ventricle dysfunction and pulmonary hypertension in hemodynamically stable pulmonary embolism.

Golpe R, Pérez-de-Llano LA, Castro-Añón O, Vázquez-Caruncho M, González-Juanatey C, Veres-Racamonde A, Iglesias-Moreira C, Fariñas MC.

Respir Med. 2010 Sep;104(9):1370-6. doi: 10.1016/j.rmed.2010.03.031. Epub 2010 Apr 24.

41.

Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma.

Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M.

Eur Respir J. 2010 Jun;35(6):1221-7. doi: 10.1183/09031936.00118809. Epub 2009 Dec 8.

42.

[Effective anti-immunoglobulin-E antibody treatment of a patient with allergic bronchopulmonary aspergillosis].

Quintás Vázquez LM, Ortiz Piquer M, Pérez de Llano LA.

Arch Bronconeumol. 2009 Apr;45(4):207. doi: 10.1016/j.arbres.2008.05.007. Epub 2009 Mar 14. Spanish. No abstract available.

43.

Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications.

Pérez de Llano LA, Golpe R, Piquer MO, Racamonde AV, Caruncho MV, López MJ, Fariñas MC.

Respiration. 2008;75(1):34-9. Epub 2007 Jul 6.

PMID:
17622772
44.

[Diagnosis of pulmonary thromboembolism by computed tomographic angiography of the chest].

Pérez de Llano LA.

Arch Bronconeumol. 2007 Jun;43(6):352; author reply 352-3. Spanish. No abstract available.

45.

Safety of withholding anticoagulant therapy in patients who have clinically suspected pulmonary embolism and negative results on helical computed tomography.

Pérez de Llano LA, Veres Racamonde A, Ortiz Piquer M, López Díaz MJ, Janeiro Amela M, Méndez Maroto L, Vázquez Caruncho M, Gómez Lafoz J.

Respiration. 2006;73(4):514-9. Epub 2005 Sep 29.

PMID:
16195662
46.

Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome.

Pérez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vázquez Caruncho M, Caballero Muinelos O, Alvarez Carro C.

Chest. 2005 Aug;128(2):587-94.

PMID:
16100142
47.

[Multicenter, prospective study comparing enoxaparin with unfractionated heparin in the treatment of submassive pulmonary thromboembolism].

Pérez de Llano LA, Baloira Villar A, Veres Racamonde A, Veiga F, Golpe Gómez R, Pajuelo Fernández F.

Arch Bronconeumol. 2003 Aug;39(8):341-5. Spanish.

48.

[Churg-Strauss syndrome in an asthmatic man treated with montelukast: continued controversy].

Pérez de Llano LA, Veres Racamonde A, Parra Arrondo A.

Arch Bronconeumol. 2002 May;38(5):251. Spanish. No abstract available.

49.

[Severe hypoxemia due to interauricular right-to-left shunt in a patient with pulmonary hypertension].

Veres Racamonde A, González Juanatey C, Pérez De Llano LA.

Arch Bronconeumol. 2002 Feb;38(2):100. Spanish. No abstract available.

50.

Bronchiolitis obliterans with organizing pneumonia associated with acute Coxiella burnetii infection.

Pérez de Llano LA, Racamonde AV, Bande MJ, Piquer MO, Nieves FB, Feijoo AR.

Respiration. 2001;68(4):425-7.

PMID:
11464095

Supplemental Content

Loading ...
Support Center